Treatment of Osteomyelitis in Adults When Bone Culture Is Positive for Methicillin-Resistant Staphylococcus aureus

When an adult patient with osteomyelitis undergoes bone culture and the result returns positive for methicillin-resistant Staphylococcus aureus (MRSA), antibiotic selection must be driven specifically by that culture finding — a different approach than for other organisms.

Clinical Scenario

Adult with osteomyelitis; bone culture positive for methicillin-resistant Staphylococcus aureus (MRSA). The choice of antibiotic therapy is specific to the culture results.

Antibiotic Approach

Initial therapy for MRSA-confirmed osteomyelitis involves targeted antibiotic agents with demonstrated activity against methicillin-resistant organisms. Multiple evidence-based options exist — the complete regimen, including agent selection, dosing, and duration, is available in the full structured protocol.

Instant Access to Structured Evidence-Based Regimens

References

The choice of antibiotic therapy is specific to the culture results listed in Table 3.
Initial Antibiotic Therapy for Osteomyelitis in Adults
Staphylococcus aureus, methicillin resistant
Daptomycin (Cubicin), 6 mg per kg IV every 24 hours
Linezolid, 600 mg IV or orally every 12 hours
Clindamycin, 600 mg IV or orally every 8 hours
Trimethoprim/sulfamethoxazole, 3.5 to 4.0 mg per kg per dose or 2 double-strength tablets (for an 80-kg [176-lb] adult) IV or orally every 8 to 12 hours

View source ↗